0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

LYMPHOSARCOMA OF THE PROSTATE GLAND

WILLIAM KAUFMANN, M.D.; ARTHUR W. WRIGHT, M.D.
Arch Surg. 1941;43(6):1061-1075. doi:10.1001/archsurg.1941.01210180130004.
Text Size: A A A
Published online

Among primary malignant prostatic tumors, those of lymphoid origin are considered to be extremely rare. To date, however, a fair number of cases of so-called primary lymphosarcoma of the prostate gland have been reported, but the great majority of them have been discarded by recent investigators on the ground that insufficient clinical or histologic evidence was presented to justify the diagnosis. Since carcinoma is the most frequent type of primary malignant tumor of the prostate gland and since many of these prostatic new growths may be composed of primitive, highly undifferentiated cells, a majority of the tumors reported as lymphosarcoma have been looked on as highly anaplastic carcinoma which was called lymphosarcoma by mistake. A strong point in favor of the rarity of lymphosarcoma in this organ is the absolute paucity, not to say absence, of lymphoid tissue from which primary lymphosarcoma could arise. We shall come back to this

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();